A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis-Reference-Cited by-同舟云学术

A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis

Published:2020-05 Issue:5 Volume:72 Page:816-827
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Harrison Stephen A.,Goodman Zachary,Jabbar Abdul,Vemulapalli Ravi,Younes Ziad H.,Freilich Bradley,Sheikh Muhammad Y.,Schattenberg Jörn M.,Kayali Zeid,Zivony Adam,Sheikh Aasim^ORCID,Garcia-Samaniego Javier,Satapathy Sanjaya K.^ORCID,Therapondos George^ORCID,Mena Edward,Schuppan Detlef,Robinson James,Chan Jean L.,Hagerty David T.^ORCID,Sanyal Arun J.

Funder

Conatus Pharmaceuticals, Inc.

Novartis

Publisher

Elsevier BV

Subject

Hepatology

Reference38 articles.

1. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity;Browning;Hepatology,2004

2. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults;Vernon;Aliment Pharmacol Ther,2011

3. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up;Ekstedt;Hepatology,2015

4. Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease;Mittal;Clin Gastroenterol Hepatol,2016

5. Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study;Piscaglia;Hepatology,2016

Cited by 185 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities;European Journal of Medicinal Chemistry;2024-11

3. Breakthrough in the Treatment of Metabolic Associated Steatotic Liver Disease: Is it all over?;Digestive and Liver Disease;2024-09

4. Intricate interplay between cell metabolism and necroptosis regulation in metabolic dysfunction-associated steatotic liver disease: A narrative review;Metabolism;2024-09

5. Revisiting the potential of regulated cell death in glioma treatment: a focus on autophagy-dependent cell death, anoikis, ferroptosis, cuproptosis, pyroptosis, immunogenic cell death, and the crosstalk between them;Frontiers in Oncology;2024-08-09